Analysis of pharmaceutical market of nootropic drugs in Ukraine
DOI:
https://doi.org/10.15587/2313-8416.2015.54873Keywords:
analysis, pharmaceutical market, Ukraine, nootropic drugs, herbal medicinal products, synthetic medicinal products, drug nomenclatureAbstract
Diseases of the nervous system takes one of the key place in disease distribution and mortality all over the world. According to the data of WHO near 30 % of population takes nootropic drugs regularly. For older people this specific part in modern society increases inexorably. This parameter reaches approximately 50 %. Although it should be noted that incidence of nervous system diseases rises in young people too. These facts prove about actuality and much need for medicinal drugs of abovementioned class, particularly, nootropic drugs which are most commonly used for neurotherapy.
Aim. The aim of this research was carrying-out of analytical review of pharmaceutical market of nootropic drugs in Ukraine.
Methods. Statistical and marketing methods of investigation of electronic and paper sources of information. Object of research is an information about nootropic drugs registered in Ukraine.
Results. It has been found that Ukrainian pharmaceuticals compose 57 % of nootropics’ market. There are 16 producing countries of nootropic drugs on Ukrainian market. Investigation of nootropics’ market showed that these drugs present in different dosage forms (tablets, capsules, syrups, pills, suspensions, solutions for injection, solutions for infusion, oral solutions, sachets), among which tablets prevail.
Conclusions. Synthetic nootropic drugs prevail and compose 87 % of Ukrainian market, fraction of herbal drugs is 13 %, and they are characterized with monotonic content and represented with medicinal products of Ginkgo Biloba. Results concerning dosage forms’ ratio prove that herbal medicinal products having nootropic action are mostly presented in the form of tablets (67 %)
References
Avedisova, А.S., V. І. Ahapkin (2001). Analysis of foreign investigations of nootropic drugs. Russian Psychiatric Journal, 1, 57–63.
Damulin, I. V. (2002). Alzheimer's disease and vascular dementia. Moscow, 85.
Grundman, M. (2001). Current therapeutic advances in Alzheimer's disease. In: Research and practice in Alzheimer's disease. Vol. 5. Springer Publishing Company. New York, 172–177.
Yachno, М. М., I. V. Damulin, I. S. Preobragenska, Е. А. Mhitayan (2003). Alzheimer's disease and dementia with Lewy bodies: some aspects of clinic, diagnostics and treatment. Мedical journal, 11 (10), 567–570.
Burchinsky, S. G. (2002). Pramiracetam is a nootropic drug of new generation from pharmacology to clinic. Ukrainian medicinal products, 3-4, 1–8.
Vinnichuk, S. М. (2006). Oxidative stress at acute ischemic stroke and its correction by antioxidant mexidol. International journal of neurology, 4, 45–52.
Korshunov, А. М., Preobragenska, I. S. (1989). Programmed cell-death (apoptosis). Journal of Neurology, 1, 40–47.
Preobragenska, I. S., Jahno, M. M. (2002). Alzheimer's disease: pathogenesis, clinic, treatment. Мedical journal, 10 (25), 1143–1147.
Putilina, М. V. (2006). Modern understanding about nootropic drugs. Physician in charge: Journal for practitioner, 5, 10–14.
Mashkovsky, M. D. (2008). Drug products. Мoscow: New wave, 1206.
Bullock, R. (2002). New drugs for Alzheimer's disease and other dementias. The British Journal of Psychiatry, 180 (2), 135–139. doi: 10.1192/bjp.180.2.135
Avarez, X. A., Ruether, E., Moessler, H. (2001). Efficacy of cerebrolysin in moderate to moderately severe Alzheimer's disease. In: Research and practice in Alzheimer's disease. Vol. 5. Springer Publishing Company, New York, 179–186.
List of nootropic drugs, approved for usage in Ukraine (2011). Ukrainian medicinal products, 4 (150), 132–135. Available at: http://nbuv.gov.ua/j-pdf/likukr_2011_4_26.pdf
Chernykh, V. P. (Ed.) (2010). Pharmaceutical encyclopedia. Kyiv: "Morion", 1632.
Specific medical online media for doctros, pharmaceutists, pharmacists, students of medical and pharmaceutical HEIs. Compendium. Drug products on-line. Available at: http://compendium.com.ua
Downloads
Published
Issue
Section
License
Copyright (c) 2015 Олена Валеріївна Савельєва, Інна Миколаївна Владимирова, Ганна Сергіївна Шумова
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
